Skip to content

Prospective multicenter study of the effectiveness of NBI magnified endoscopy with acetic acid for the diagnosis of histological type of early gastric cancer.

Prospective multicenter study of the effectiveness of NBI magnified endoscopy with acetic acid for the diagnosis of histological type of early gastric cancer. - Acetic acid NBI study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006042
Enrollment
250
Registered
2011-08-01
Start date
2011-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer, depressed type

Interventions

None listed

Sponsors

Saku Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who have an early gastric cancer treated by ESD (endoscopic submucosal dissection)

Exclusion criteria

Exclusion criteria: 1. The patients who rejected informed consent. 2. The patients who were treated by chemotherapy or radiation therapy. 3. The patients without tolerability for prolonged sedation. 4. The diameter of lesion is more over 4cm in size.

Design outcomes

Primary

MeasureTime frame
Accuracy rate of the diagnosis of histological type (White light endoscopy, NBI magnified endoscopy vs. acetic acid NBI magnified endoscopy)

Countries

Japan

Contacts

Public ContactKISHINO TAKAAKI

Saku Central Hospital Gastroenterology

kishinotakaaki@hotmail.co.jp0267-82-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026